Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar ...
Accelerated repetitive transcranial magnetic stimulation appears to be effective for treatment-resistant depression.
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...
Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...
Compared with usual care, use of the PETRUSHKA tool increased the number of patients still taking their antidepressant at 8 weeks and improved depressive and anxiety symptoms at 24 weeks. However, ...
When people struggle with anxiety and depression, the most effective approach is often to combine medication and ...
TAMPA, FL - March 05, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has released a new educational resource ...
USA: Major Depressive Disorder (MDD), a debilitating psychiatric condition affecting millions worldwide, shares a distinct Type 2 helper T-cell (Th2) immune signature with atopic dermatitis (AD), ...
DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting psychedelic approach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results